Merogenomics Inc.

enefit them personally, participation will grow and procedural costs will shrink, making a personalized approach to medicine available to everyone. was conceived to make the benefits of genome sequencing accessible to the general public. The public’s benefit is our main goal and we aim to achieve that through spreading awareness about the use of this technology, by studying its maximal benefit potential for personal investigation, and by ensuring that each user will experience the highest standard of safety. We believe that the public should take an active role in determining the best utility of this emerging technology, and directly participate in shaping our collective knowledge from biological, ethical, and legal points of view. seek to promote awareness about the best societal use and economic value of genomic technologies among governmental agencies, policy makers, industry stake holders, patient advocacy groups, and commercial interests.